132 related articles for article (PubMed ID: 22502709)
1. Associations between adiponectin and two different cancers: breast and colon.
Gulcelik MA; Colakoglu K; Dincer H; Dogan L; Yenidogan E; Gulcelik NE
Asian Pac J Cancer Prev; 2012; 13(1):395-8. PubMed ID: 22502709
[TBL] [Abstract][Full Text] [Related]
2. Relation of serum adiponectin levels and obesity with breast cancer: a Japanese case-control study.
Minatoya M; Kutomi G; Shima H; Asakura S; Otokozawa S; Ohnishi H; Akasaka H; Miura T; Mori M; Hirata K
Asian Pac J Cancer Prev; 2014; 15(19):8325-30. PubMed ID: 25339024
[TBL] [Abstract][Full Text] [Related]
3. Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients.
Hancke K; Grubeck D; Hauser N; Kreienberg R; Weiss JM
Breast Cancer Res Treat; 2010 Jan; 119(2):367-7. PubMed ID: 19842034
[TBL] [Abstract][Full Text] [Related]
4. Roles of adiposity, lifetime physical activity and serum adiponectin in occurrence of breast cancer among Malaysian women in Klang Valley.
Shahar S; Salleh RM; Ghazali AR; Koon PB; Mohamud WN
Asian Pac J Cancer Prev; 2010; 11(1):61-6. PubMed ID: 20593932
[TBL] [Abstract][Full Text] [Related]
5. Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer.
Al Khaldi RM; Al Mulla F; Al Awadhi S; Kapila K; Mojiminiyi OA
Dis Markers; 2011; 30(4):197-212. PubMed ID: 21694446
[TBL] [Abstract][Full Text] [Related]
6. Relationship of serum adiponectin and resistin levels with breast cancer risk.
Kang JH; Yu BY; Youn DS
J Korean Med Sci; 2007 Feb; 22(1):117-21. PubMed ID: 17297263
[TBL] [Abstract][Full Text] [Related]
7. Anthropometric measures, plasma adiponectin, and breast cancer risk.
Tian YF; Chu CH; Wu MH; Chang CL; Yang T; Chou YC; Hsu GC; Yu CP; Yu JC; Sun CA
Endocr Relat Cancer; 2007 Sep; 14(3):669-77. PubMed ID: 17914097
[TBL] [Abstract][Full Text] [Related]
8. Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk.
Minatoya M; Kutomi G; Asakura S; Otokozawa S; Sugiyama Y; Ohnishi H; Akasaka H; Miura T; Mori M; Hirata K
Breast Cancer; 2015 Sep; 22(5):452-61. PubMed ID: 24166746
[TBL] [Abstract][Full Text] [Related]
9. Associations of insulin resistance and adiponectin with mortality in women with breast cancer.
Duggan C; Irwin ML; Xiao L; Henderson KD; Smith AW; Baumgartner RN; Baumgartner KB; Bernstein L; Ballard-Barbash R; McTiernan A
J Clin Oncol; 2011 Jan; 29(1):32-9. PubMed ID: 21115858
[TBL] [Abstract][Full Text] [Related]
10. Adipocytokines and breast cancer risk.
Hou WK; Xu YX; Yu T; Zhang L; Zhang WW; Fu CL; Sun Y; Wu Q; Chen L
Chin Med J (Engl); 2007 Sep; 120(18):1592-6. PubMed ID: 17908478
[TBL] [Abstract][Full Text] [Related]
11. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
[TBL] [Abstract][Full Text] [Related]
12. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
13. Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India.
Sultana R; Kataki AC; Borthakur BB; Basumatary TK; Bose S
Gene; 2017 Jul; 621():51-58. PubMed ID: 28414093
[TBL] [Abstract][Full Text] [Related]
14. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
15. [Association Between Plasma Adiponectin and Risk of Breast Cancer by Molecular Subtypes].
Li JC; Yi F; Diao S; Li JY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Sep; 50(5):708-713. PubMed ID: 31762242
[TBL] [Abstract][Full Text] [Related]
16. Serum adiponectin but not leptin at diagnosis as a predictor of breast cancer survival.
Lee SA; Sung H; Han W; Noh DY; Ahn SH; Kang D
Asian Pac J Cancer Prev; 2014; 15(15):6137-43. PubMed ID: 25124587
[TBL] [Abstract][Full Text] [Related]
17. Association between adiponectin, insulin resistance, and endometrial cancer.
Soliman PT; Wu D; Tortolero-Luna G; Schmeler KM; Slomovitz BM; Bray MS; Gershenson DM; Lu KH
Cancer; 2006 Jun; 106(11):2376-81. PubMed ID: 16639730
[TBL] [Abstract][Full Text] [Related]
18. [Obesity and adipocytokines in breast cancer and benign breast disease].
Quiroga-Morales LA; Sat-Muñoz D; Martínez-Herrera BE; Alcántara-Cadillo RR; Macías-López GG; García-Cobián TA; Bañuelos-Rizo M; Balderas-Peña LMA
Rev Med Inst Mex Seguro Soc; 2018 Oct; 56(3):246-254. PubMed ID: 30376276
[TBL] [Abstract][Full Text] [Related]
19. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
[TBL] [Abstract][Full Text] [Related]
20. The Effects of Adjuvant Endocrine Treatment on Serum Leptin, Serum Adiponectin and Body Composition in Patients with Breast Cancer: The Izmir Oncology Group (IZOG) Study.
Akyol M; Demir L; Alacacioglu A; Ellidokuz H; Kucukzeybek Y; Yildiz Y; Gumus Z; Bayoglu V; Yildiz I; Salman T; Varol U; Kucukzeybek B; Demir L; Dirican A; Sutcu R; Tarhan MO
Chemotherapy; 2016; 61(2):57-64. PubMed ID: 26571369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
